ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000263393.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.015250516	Sensitive
ENSG00000263393.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.025503346	Sensitive